Publication | Closed Access

Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness

Reimbursement DecisionsHealthcare ValueHealth EconomicsHealth PolicyDisease SeverityHealth Care ReimbursementOutcomes ResearchHealth Services CompetitionPharmacoeconomicsHealth Care CostCost EffectivenessPublic HealthEconomic EvaluationMedicineFinancingHealth Services Research